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a  b  s  t  r  a  c  t
Maternal  exposure  to a carcinogen  is  associated  with  increased  risk  of  different  cancers
in the  offspring.  The  foetus  is highly  sensitive  to carcinogens  and  this  contributes  to the
foetal  basis  of the  onset  of  disease.  The  better  understanding  of  the  molecular  mechanisms
involved  in  the  early  stage  of  lung  tumourigenesis  in  the offspring  is needed  for the  newer
preventive  strategies.  We  evaluated  the  effects  of  N-ethyl-N-nitrosourea  (ENU)  given  on
the 17th  day  of  gestation  and  antitumour  agent  inositol  hexaphosphate  (IP6)  to  the  moth-
ers  at  the early  stage  of  lung  tumourigenesis  in  F1 mice.  There was  no  treatment  related
effects  on the  litter  size  or  body  weight  of  the  F1 mice  at the PND12  or  24.  Analysis  of
PCNA,  NF-B  (p50),  IL-6,  COX-2,  pSTAT3,  STAT3,  caspase-3,  caspase-9,  PARP,  Akt  signalling
and  downstream  cyclin  D1  along  with  miR-155,  suggested  the  modulation  of  proliferation,
inﬂammation  and  apoptosis  at PND12  and  24.  IP6  administration  to the  predisposed  moth-
ers prevented  the  proliferation,  inﬂammation  and  enhanced  apoptosis  in  F1  lung  as  showed
by a reduction  in PCNA,  NF-B  (p50),  IL-6, COX-2,  pSTAT3,  STAT3,  miR-155  and  increase
in  caspases,  cleavage  of poly  (ADP-ribose)  polymerase.  IP6  administration  also inhibited
the  activation  of  Akt and  cyclin  D1. Our  study  shows  that  tumourigenic  changes  take place
in the  lungs  of  the  F1 generation  from  the carcinogen  predisposed  mothers  even before
the  onset  of  tumours  and  the  simultaneous  intake  of chemopreventive  agent  during  the
gestation  or  lactation  period  could  prevent  the lymphocytic  inﬁltration  and  hyperplasia
preceding  the tumourigenesis.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe  CC  B
1. IntroductionExposure of carcinogen during pregnancy is associ-
ated with impacts on offspring diseases like cancer [1].
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N-ethyl-N-nitrosourea (ENU), a mutagen related to the
family of N-nitroso compounds, is found in fumigants,
biohazard and interacts with DNA forming adducts before
causing the cancer in the developing foetus [2,3]. The
foetus is highly sensitive to toxicity from chemical car-
cinogen that contributes to the onset of different cancer
like liver, lung and kidney in offspring [1,4]. Use of ENU in
mouse model for the transplacental tumour development
has been used to evaluate the risk or effects associated
with mutagens and carcinogens in the human population
[3,5–7]. We  have also shown that maternal ENU exposure
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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uring pregnancy results in lung tumours in the offspring
n adulthood [3]. However, the molecular mechanisms
emain to be explored in the early stages in the offsprings
rom the carcinogen predisposed mothers.
Emerging studies demonstrated that an early induction
f cell proliferation, inﬂammation and inhibition of apopto-
is may  lead the development of a tumour at a later stage
8,9]. PCNA, an early cell proliferation marker expressed
uring S and G2 phases of the cell cycle, is found to be
ighly expressed during carcinogenesis and plays a central
ole in DNA replication, repair and cell cycle progression
10]. Nuclear factor kB (NF-B), a family of transcription
actors, has been showed to regulate growth, inﬂammation
nd apoptosis in different tissues [11]. Cyclooxygenase-
 (COX-2), involved in inﬂammation, cell proliferation
nd cell death, is also regulated by the activation of NF-
B [12] resulting in the regulation of pro-inﬂammatory
ytokines (IL-6) and chemokines gene expression. Further,
ctivation of transcription factor STAT3 by phosphoryla-
ion in turn activates the transcription of genes implicated
n inﬂammation and cancer [13]. Targeted inhibition of
nﬂammatory mediators at the initial phase is valuable for
ot only alleviating inﬂammation, but also preventing the
nset of cancer.
Enhanced cellular proliferation and deregulated apo-
tosis are prominent early cellular features after carcino-
en exposure [14]. In apoptosis, caspase-3 gets activated
hrough caspase-8 or caspase-9 and leads to the cleav-
ge of poly (ADP-ribose) polymerase (PARP) causing DNA
ragmentation [15] and suggesting the onset of apoptosis.
kt signalling is a critical in cancer because it contributes
o tumourigenesis, tumour growth and therapeutic resis-
ance. Activation of Akt is an early response to carcinogen
xposure that promotes cell survival by activating the NF-
B signalling pathway and inhibiting apoptosis [16–18].
ctivated Akt, the serine 473 phosphorylation, results in
he activation of a cascade of different protein targets
ncluding NF-B and cyclin D1 [19–21]. MicroRNAs (miR-
As), around 21 nucleotides long non-coding RNA, play
n important role in regulating the expression of multiple
enes [22,23]. Recent studies have shown that miRNA could
e among the potential biomarkers for various cancers
24]. Overexpressed miR-155 promotes cell proliferation
nd inhibit apoptosis in breast, lung and colon cancers,
ut the speciﬁc mechanism of action of miR-155 remains
o be understood [25,26]. The downregulation of miR-155
xpression is also associated with induction of apoptosis
hrough the activation of caspases in non-small-cell lung
ancer [24,26,27].
Chemopreventive approaches are more effective in
reventing and controlling the onset of diseases [28].
hemopreventive agents including plant products and
ietary constituents are shown to prevent the development
f tumours [29].
A chemopreventive agent effectively regulates cell pro-
iferation, inﬂammation and inducing apoptosis [28–30].
owever, clinical trials with some agents like retinoid,
lpha-tocopherol and carotenoid are not successful
nstead; adverse tumour promoting effects were observed.
n view of above, we tried to look for the early changes in
1 mouse lungs from the carcinogen predisposed mothersrts 2 (2015) 590–599 591
and the effects of inositol hexaphosphate (IP6), a naturally
occurring nontoxic sugar phosphate mostly present in high
ﬁbrous food sources such as cereals, legumes, nuts and
soybean. It is also present in almost all the plant and mam-
malian cells [36]. Others and we  have used the 2% IP6 in
drinking water in the chronic animal experiments to study
the tumourigenesis and chemoprevention without show-
ing any toxic effects [3,31,33]. IP6 has been shown to inhibit
cell proliferation and induce apoptosis in different model
[32]. However, the understanding of the potential molec-
ular mechanism responsible for its anti-proliferative and
apoptotic activity is limited [3]. Present study is aimed to
elucidate the early changes during the lactation period in
F1 mouse lungs from the predisposed mothers to be used
for the cancer control.
2. Material and methods
2.1. Animals
Female and male, Balb/c mice (6–8 weeks of age) were
procured from the inbred colony of CSIR-IITR, Lucknow.
Male mice were used for the purpose of mating. Mice were
housed under a 12-h light:dark cycle and were kept on solid
pellet diet (M/S Provini Animal Nutrition India Pvt. Ltd.,
Bangalore) and water ad libitum. They were acclimatized
for one week before the start of the experiments.
2.2. Chemicals and reagents
N-ethyl-N-nitrosourea and inositol hexaphosphate
were procured from Sigma Co. (USA). [methyl-3H] thymi-
dine (speciﬁc activity 17.20 Ci/mmol) was  provided by
BRIT, Mumbai, India. Caspase-3 or -9 enzyme activity assay
kit was  procured from R&D system, USA. The Super Signal
West Femto Max  Substrate was  procured from Thermo Fis-
cher Scientiﬁc, USA. Primary antibodies for PCNA, cyclin D1,
NF-B (p50), IL-6, STAT3, pSTAT3, pAkt, PARP, caspase-3
and caspase-9 were purchased from Santa Cruz Biotech-
nologies, USA and antibodies for COX-2, Akt and -actin
were from Cell Signalling Technology, USA. The rest of the
chemicals were purchased from local commercial sources
and were of analytical grade.
2.3. Study design and treatment schedule
After one week of acclimatization, the breeding process
was initiated by placing female and male mice in a ratio
of 2:1. The day of the appearance of the vaginal plug was
considered as day zero of gestation. Sixteen pregnant mice
were randomly divided into four groups consisting of four
mice each. Each mouse was  housed individually. The four
groups of studies were control, IP6, ENU, and ENU + IP6.
Group I pregnant mice (control) received only 50 mM cit-
rate buffer (pH-6.0) i.p. on the 17th days of gestation. Group
II pregnant mice (IP6) received 2% IP6 in drinking water
from the 17th days of gestation. Group III pregnant mice
(ENU) received ENU at a dose of 40 mg/kg body weight
dissolved in 50 mM citrate buffer pH-6.0 on the 17th days
of gestation. Group IV pregnant mice (ENU + IP6) received
ENU at a dose of 40 mg/kg body weight dissolved in 50 mM
592 S. Sahay et al. / Toxicology Reports 2 (2015) 590–599
Table  1
Treatments schedule.
Treatment group No. of pregnant mice Treatment on 17th days of gestation No. of pups/group
Control 4 50 mM citrate buffer pH-6.0 (i.p.) 15–20
 water 
rate buf
rate bufIP6  4 2% IP6 in drinking
ENU  4 ENU in 50 mM cit
ENU  + IP6 4 ENU in 50 mM cit
citrate buffer pH-6.0 on the 17th days of gestation along
with 2% IP6 in drinking water. Dose selection of ENU and
IP6 was based on earlier studies from our and other labo-
ratories [3,5,31,33]. All the treatments were continued for
postnatal day (PND) 12 or 24 after the pups were delivered.
Pups (n = 15–20) from each group were sacriﬁced at PND12
or 24 (Table 1). The lungs were harvested. Lungs from one
third of the mice from each group were ﬁxed in buffered
formalin for histopathological analysis and lungs from the
rest of the mice were taken out and processed for molecular
studies.
2.4. Histopathology
At the time of termination, lungs from each mouse were
perfused, washed in phosphate buffered saline (PBS) and
ﬁxed in 10% buffered formalin. Tissues were embedded
in parafﬁn wax and 5 m thick median transverse sec-
tions were cut serially. Sections were de-parafﬁnized using
xylene and graded concentrations of ethanol. Sections were
then stained and counterstained with haematoxylin and
eosin (H&E) to be examined under the light microscope for
microscopic examination and photographed (100×) [33].
2.5. [methyl-3H] Thymidine incorporation in F1 mouse
lung DNA
The [methyl-3H] thymidine incorporation assay was
performed to assess the DNA synthesis in the F1 mouse
lungs from the predisposed mothers following the method
as described [34]. Here, a radioactive nucleoside is incor-
porated into new strands of chromosomal DNA during
cell division. Pups from the four groups as described ear-
lier were given intra-peritoneal injection of [methyl-3H]
thymidine (33.0 Ci/animal in 0.1 ml  normal saline) 1 h
prior to the termination of the experiment at PND12 or
24. At the end of 1 h, animals were sacriﬁced; lungs were
taken out and processed to prepare the acid hydrolysate
for the DNA analysis as described. Acid hydrolysate, thus
obtained, was used for DNA estimation and radioactivity
counting. The concentration of DNA was read at 600 nm in
spectrophotometer (BioRad, USA).
2.6. Real-time polymerase chain reaction for the status of
miR-155 expression
Total RNA enriched with micro RNA was isolated using
TRIzol reagent (Invitrogen, USA) according to the manufac-
turer’s instructions. For the evaluation of miR-155, 1 g of
total RNA was reverse transcribed using a miScript II RT
kit (Qiagen, The Netherlands) and micro RNA levels were
quantiﬁed in ABI Step One plus thermo cycler (Applied15–20
fer pH-6.0 (i.p.) 15–20
fer pH-6.0 (i.p.) and 2% IP6 in drinking water 15–20
Biosystems, USA) using gene speciﬁc forward primer 5′-
TTAATGCTAATTGTGATAGGGGT-3′ for miR-155. A primer
for reference control U6 was  5′-TGGCCCCTGCGCAAGGATG-
3′ and miScript universal reverse primer was  as provided
with the kit. Brieﬂy, 1 l (10 ng) of cDNA was incubated
with 1×QuantiTect SYBR PCR master mix, 1×miScript uni-
versal primer, 0.5 pmol gene speciﬁc forward primer. The
reaction was run for 15 min  at 95 ◦C, followed by 40 cycles
of 15 s at 94 ◦C, 30 s at 55 ◦C and 30 s at 70 ◦C. U6 was used
as an endogenous control to normalize the gene expres-
sion. Relative expression of miR-155 was analyzed by using
2Ct values [35].
2.7. Analysis of protein expression by SDS-PAGE and
western blotting
Lung tissue lysate was  prepared in the 20 mM Tris–HCl
(pH 7.5) buffer containing 2 mM sucrose, 2 mM EDTA,
0.5 mM EGTA, 2 mM MgCl2, 2 mM PMSF, 1 mM DTT,
0.03 mM Na3VO4 and protease inhibitor cocktails (Sigma
Co., USA). Protein concentration was quantiﬁed by Brad-
ford’s method. Tissue lysate equivalent to 50 g of protein
was  resolved on to 8–12.5% Tris–glycine gel and transferred
onto an Immobilion-P-membrane (PVDF) (Millipore, USA)
for 1 h at 90 V. Subsequently, membranes were blocked
with 3% BSA in TBST (100 mM Tris–HCl, 150 mM NaCl and
0.1% Tween-20) for 1 h and probed with the primary anti-
bodies for PCNA, cyclin D1, NF-Bp50, IL-6, STAT3, pSTAT3,
pAkt, PARP, caspase-3, caspase-9, COX-2 and Akt at a dilu-
tion 1:3000. Further incubation was  done with appropriate
secondary antibodies conjugated to horseradish peroxi-
dase (Bangalore Genei, India) at a dilution 1:10,000. The
immunocomplex, thus formed, was visualized with the
help of Super Signal West Femto Max  Substrate in Versa
Doc Gel Imaging System (Bio-Rad, Hercules, CA) and quan-
tiﬁed using Gene Tool Syngene software. Each membrane
was  stripped and re-probed with -actin as a loading con-
trol.
2.8. Immunohistochemical analysis of protein expression
To assess the localization of PCNA and caspase-3
(17 kDa), immunohistochemistry (IHC) was  performed
in F1 lung tissue sections following the earlier reported
method with slight modiﬁcations [35]. 5 m parafﬁnized
sections were dewaxed with xylene, hydrated in a
descending series of alcohol and rinsed with water and
blocked with horse serum for 30 min. Primary antibodies
for PCNA and cleaved caspase-3 were used at a dilution
1:300 overnight in a moist chamber. ABC reagent was  used
with HRP conjugated secondary antibodies according to
Vecta stain kit (Vector Lab). DAB was  used as HRP substrate
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or protein localization. Random micrographs were taken
rom DAB stained lung tissue section of the magniﬁcation of
00× and signal intensity was analyzed using open source
mageJ1.47v software, (National Institutes of Health, USA).
.9. Estimation of the enzyme activity of the caspase-9
nd -3
Enzyme activities of caspase-9 and caspase-3 were
ssessed in cytosolic fractions using a colorimetric assay
it from R&D system, USA. Brieﬂy, fresh tissue lysate
as prepared in lysis buffer from the kit and 100,000 × g
raction was collected. 50 l cytosolic fractions contain-
ng 100–150 g proteins were added to 50 l 2× reaction
uffers containing 10 mM DTT in a 96-well plate. 5 l of
 mM substrate (DEVD-pNA for caspase-3 or LEHD-pNA
or caspase-9) was added to each sample and incubated at
7 ◦C for 2 h in dark condition. At the end, coloured complex
as read at 405 nm in a microplate reader (BMG Labtech).
nzyme activity has been expressed in terms of optical den-
ity/mg protein/h in ﬁgures [3].
.10. Detection of DNA fragmentation by TUNEL assay
DNA fragmentation, a hallmark of apoptosis was
etected by terminal deoxynucleotidyl transferase (Tdt)
ediated dUTP nick end-labelling (TUNEL). The procedure
as carried out using a TACS 2TdT DAB kit from Trevi-
en, USA, according to the manufacturer’s protocol. TUNEL
ositive signals were visualized using the horseradish
eroxidase-mediated diaminobenzidine (DAB) stain. Cell
uclei were counterstained with a methyl green solution as
escribed elsewhere [3]. Random micrographs were taken
rom DAB stained lung tissue section from each group at
he magniﬁcation of 400× and signal intensity was  ana-
yzed using open source ImageJ1.47v software (National
nstitutes of Health, USA) [35].
.11. Statistical analysis
Data were expressed as mean ± SE. Statistical analysis
f gene expression was performed using the Graph Pad
rism (version 5.0, Graph Pad Software Inc., USA). ANOVA
as performed taking mean values for comparing between
roups and statistical signiﬁcance was determined in terms
f ‘P’ values with the help of Newman–Keuls test analysis.
. Results
.1. Gross examination
There were no signiﬁcant differences in the male:female
atio, litter size and body weight of the F1 mice between any
f the treatment groups at the end of PND12 and 24. There
as no abnormality like any lesion or tumourous growthn the F1 lungs from any group of treatment.
Administration of 2% IP6 in drinking water did not show
ny effect on the water consumption by the mice in any
roup in the present study.rts 2 (2015) 590–599 593
3.2. Microscopic examination of F1 mouse lungs
H&E staining of parafﬁn-embedded tissue sections
could not show any alteration in the histology of lungs
from the control or IP6 treated group. Lungs from F1 mice
from ENU exposed mother showed distinct histopatho-
logical changes in terms of lymphocytic inﬁltration at
PND12. Lymphocytic inﬁltration was  increased further and
hyperplasia started appearing at PND24. Whereas, F1 mice
from the ENU exposed mothers drinking IP6 during this
period showed reduced lymphocytic inﬁltration at both
the PND12 and 24. Under this condition, an inhibition was
also observed in the incidence of hyperplasia at the PND24
(Fig. 1-I).
3.3. Incorporation of [methyl-3H] thymidine in the DNA
of F1 mouse lungs
At the end of the treatment, [methyl-3H] thymidine
incorporation into lung DNA and the status of DNA syn-
thesis was evaluated at PND12 or 24. The [methyl-3H]
thymidine incorporation in lung DNA was increased to 63
or 142% at the end of PND12 or 24 in F1 mice from ENU
exposed mothers. In F1 mice from the ENU exposed moth-
ers drinking IP6, [methyl-3H] thymidine incorporation into
DNA was  reduced (Fig. 1-II) and showed only 15 or 5% at
PND12 or 24 as compared with control.
3.4. Status of the PCNA expression
In order to support the increased [methyl-3H] thymi-
dine incorporation into DNA as a marker of proliferation,
we analyzed the expression of PCNA. PCNA protein was
overexpressed by 35 or 69% at PND12 or 24 in F1 mice
from ENU exposed mothers as compared to control. But in
F1 mice from the ENU exposed mothers drinking IP6, ENU
induced expression of PCNA protein was very signiﬁcantly
reduced and showed only 2% increase or 7% decrease at
PND12 or 24 as compared with control (Fig. 1-IIIb). Further,
the overexpression of PCNA was  supported by immuno-
histochemical analysis in F1 lung sections. ENU exposure
increased the number of PCNA positive nuclei increased by
3.36 or 3.9-fold at PND12 or 24 as compared to control. In F1
mice from the ENU exposed mothers drinking IP6, the ENU
induced PCNA positive nuclei were increased only to 2.21 or
1.36-fold at PND12 or 24 as compared with control (Fig. 1-
IVb). Higher intensity of DAB stain in the nucleus suggested
the nuclear localization of the overexpressed PCNA protein.
3.5. Status of NF-B (p50), IL-6 or COX-2 expression
Expression of NF-B(p50), IL-6 or COX-2 protein was
increased at PND12 or 24 in F1 mice from the ENU exposed
mothers as compared to control.IP6 administration to the
mothers tried to prevent this overexpression. The increase
in expression of NF-B (p50), IL6 or COX-2 was  50, 28 or
37% at PND12 and 60, 43 or 46% at PND24 in F1 mice from
the ENU exposed mothers as compared with control. In F1
mice from the ENU exposed mothers drinking IP6 during
this period, ENU induced expression of NF-B (p50), IL-6 or
COX-2 was reduced to 25, 14 or 36% at PND12 and 16, 15
594 S. Sahay et al. / Toxicology Reports 2 (2015) 590–599
Fig. 1. Histopathology, [methyl-3H] thymidine incorporation and PCNA expression. Round circle indicates lymphocytic inﬁltration and arrow indicate
hyperplasia in F1 lung from ENU exposed mothers (I). Quantitative analyses of [methyl-3H] thymidine incorporation (II). Western blot analysis of PCNA
protein and quantitative analysis are shown in (IIIa) and (IIIb). Qualitative and quantitative analyses of IHC for PCNA are shown in (IVa) and (IVb). Arrows
point out the higher DAB intensity in F1 mice from ENU exposed mothers is showing PCNA positive nuclei in F1 lung tissues section. Bars represent
mean  ± SE of triplicate. *,†P < 0.05; **,††P < 0.01; ***,†††P < 0.001; *,**,***compared with control; †,††,†††compared with ENU. PND12; PND24.
Fig. 2. Expression of inﬂammatory and cell survival genes. Western blot and quantitative analysis of COX-2, NF-B (p50), IL-6, pSTAT3, STAT3, pAkt Ser473,
Akt,  and cyclin D1 proteins are shown in (Ia), (IIa), (IIIa), (Ib,c), (IIb,c) and (IIIb,c). Bars represent mean ± SE of triplicate. *,†P < 0.05; **,††P < 0.01; *,**compared
with  control; †,†† compared with ENU. PND12; PND24.
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r 4% at PND24 as compared with control (Fig. 2-Ia–c and
Ia–c).
.6. Modulation of STAT3 as a result of IL-6
verexpression
IL-6 mediated activation of STAT3 transcription factor
y its phosphorylation is critically involved in inﬂamma-
ion. We  did not observe any treatment related change in
he expression of STAT3 at PND12 or 24, but the overex-
ression of phosphorylated STAT3 (pSTAT3) protein was
bserved in F1 mice from the ENU exposed mothers. The
xpression of p-STAT3 was upregulated by 24 or 40% at
ND12 or 24 in F1 mice from ENU exposed mothers. F1
ice from the ENU exposed mothers drinking IP6 showed
nly 1 or 6% downregulation of STAT3 at the PND12 or 24 as
ompared with control. The ratio of pSTAT3/STAT3 expres-
ion was evaluated and found to be 23 or 34% upregulated
t PND12 or 24 as compared to control. In F1 mice from
he ENU exposed mothers drinking IP6 during this period
howed the ratio of pSTAT3/STAT3 upregulated by 3 or 7%
t PND12 or 24 as compared with control (Fig. 2-IIa, c).
.7. Activation of Akt pathway
As observed, ENU could induce the proliferation as well
s inﬂammatory markers in F1 lung during the lactation
eriod. Akt pathway could also play important roles in the
egulation of cell proliferation, inﬂammation and apopto-
is. To test our hypothesis whether Akt pathway is also
nvolved in the regulation of cell proliferation, inﬂamma-
ion and apoptotic machinery in F1 mice from ENU exposed
others, we evaluated the status of Akt and the activation
f Akt by analysing phosphorylated serine 473 Akt residues.
kt expression remained unaltered at PND12 or 24 in F1
ice from ENU exposed mothers in the presence or absence
f IP6 as compared to control. However, the expression of
Akt Ser473 was upregulated by 47 or 48% at PND12 or
4 in F1 mice from ENU exposed mothers. F1 mice from
NU exposed mothers drinking IP6 showed only 2 or 1%
ownregulation at PND12 or 24 as compared with con-
rol. The ratio of pAktSer473/Akt expression increased by
5 or 38% at PND12 or 24 in F1 mice from ENU exposed
others as compared with control. In F1 mice from the
NU exposed mothers drinking IP6; this ratio did not vary
t PND12. But at PND24, this ratio showed 2% decrease as
ompared with control (Fig. 2-IIa, c). These results indicate
hat IP6 inhibits the activation of Akt at an early stage of
arcinogen exposure.
.8. Status of the cyclin D1 expression
In order to show the relationship between Akt activation
nd the status of cyclin D1, we analyzed the expression of
yclin D1 and showed a signiﬁcant increase by 50 or 60%
t PND12 or 24 in F1 mice from the ENU exposed mothers
s compared with control (Fig. 2-IIIa, b). F1 mice from the
NU exposed mothers drinking IP6 showed the reduced
verexpression of cyclin D1 which remained 25% higher or
6% lower at PND12 or 24 as compared with control.rts 2 (2015) 590–599 595
3.9. Expression of the apoptosis related proteins
We  tried to evaluate the effectors pathway of apoptosis
and showed that the expression of caspase-9 (35 kDa) or
caspase-3 (17 kDa) was  decreased by 24 or 22% at PND12
and 40 or 39% at PND24 in F1 mice from ENU exposed
mothers as compared to control (Fig. 3-Ia, b). F1 mice from
the ENU exposed mothers drinking IP6 showed a signiﬁ-
cant increase in the expressions of caspase-9 (35 kDa) or
caspase-3 (17 kDa). The increase was 11 or 1% at PND12
and 4 or 6% at PND24 in F1 mice as compared with control.
In order to conﬁrm the activation of one of the major
executors of apoptosis, we analyzed the expression of the
caspase-3 (17 kDa) by IHC (Fig. 3-IIa, b). The intensity of
the DAB stain, an indicator of the protein expression, for
the caspase-3 was  decreased to 0.56 or 0.43-fold at PND12
or 24 respectively in F1 mice from ENU exposed mothers as
compared with control. In F1 mice from the ENU exposed
mothers drinking IP6, DAB intensity of activated caspase-3
was increased to 1.07 or 1.12-fold at PND12 or 24 respec-
tively as compared with control.
3.10. Enzyme activity of the caspase-9 or caspase-3
protein
Having shown the changes in the expression of the
caspase-9 or caspase-3 protein, we performed the enzyme
assay to show the functional activities of the altered
proteins. Enzyme activity of caspase-9 or caspase-3 was
decreased to 18 or 20% at PND12 and 25 or 32% at PND24
in F1 mice from the ENU exposed mothers. In F1 mice from
the ENU exposed mothers drinking IP6, enzyme activities of
caspase-9 or caspase-3 signiﬁcantly increased to 13 or 10%
at PND12 and 25 or 22% at PND24 as compared with con-
trol. Taken together, these results suggest that IP6 drinking
mothers during lactation period regulate the functional
activities of both caspases that lead to the apoptosis in F1
mice (Fig. 3-III).
3.11. Expression of the miR-155
In order to explore the responsible factors for inhibit-
ing the apoptosis, we  evaluated the status of miR-155 that
could target the apoptosis genes like caspase-3. MiR-155
was upregulated by 2.26 or 2.74-fold at PND12 or 24 in
F1 mice from ENU exposed mothers. But F1 mice from the
mothers drinking IP6 showed only 1.32 or 1.72-fold upreg-
ulation in miR-155 expression at PND12 or 24 as compared
with control (Fig. 4-I).
3.12. Status of PARP cleavage supporting the apoptotic
events
Expression of PARP, a substrate of activated caspase-3
was analyzed to show the downstream effects of caspase-3.
The level of cleaved fragment PARP (85 kDa) was  decreased
to 35 or 42% in F1 mice from the ENU exposed mothers as
compared with control at PND12 or 24 (Fig. 4-IIa, b). IP6
tried to prevent this decrease in F1 mice from the mothers
drinking IP6 and showed only 1% decrease in the cleaved
fragment PARP expression at PND12. But the cleaved
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Fig. 3. Status of apoptotic molecules. Western blot and quantitative analysis of caspase-9 (35 kDa) and caspase-3 (17 kDa) are shown in (Ia) and (Ib).
 are sh
. *,†P < 0Qualitative and quantitative analyses of caspase-3 (17 kDa) done by IHC
enzyme activity is shown in (III). Bars represent mean ± SE of triplicate
PND12; PND24.
fragment PARP expression was increased by 6% at PND24
as compared with control.
3.13. In situ detection of DNA fragmentation to support
the status of apoptosis
In order to support the alterations in the apoptosis, we
determined the DNA fragmentation, a hallmark of apo-
ptosis, by TUNEL assay in the F1 mice lungs from ENU
exposed mothers in the presence or absence of IP6. Inten-
sity of the DAB stain corresponds to the DNA fragmentation.
DNA fragmentation as showed by DAB intensity was  inhib-
ited by 35 or 44% at PND12 or 24 in F1 mice from ENU
exposed mothers as compared with control. In F1 mice
from the mothers drinking IP6, the DNA fragmentation was
enhanced by 8 or 18% at PND12 or PND24 as compared with
control (Fig. 4-IIIa, b).
4. DiscussionThere are growing evidences that carcinogen exposure
to mothers during the gestation period could result in
the adverse effects including cancer in the offspring [1].
Experimental studies have revealed that the process ofown in (IIa) and (IIb). Quantitative analysis of caspase-9 and caspase-3
.05; **,††P < 0.01; *,**compared with control; †,††compared with ENU.
carcinogenesis can be modulated by timely intervention
by the administration of chemopreventive agent or by
intake of protective agents through regular food and drinks
[7,29,36]. Numerous epidemiological as well as experi-
mental studies have been shown that correlation between
reduced risk of cancer and intake of dietary constituent.
The intervention of carcinogenesis process in the post-
initiation stage has to be the most appropriate and practical
since this stage is reversible [37].
Appearance of lymphocytic inﬁltrations and hyperpla-
sia at the end of PND12 or 24 in F1 mice from the ENU
exposed mothers and its prevention by IP6 suggested
the exploration of the molecular events of proliferation
and inﬂammation as targets for the early management
of tumour development. Earlier reports suggest that the
alteration in proliferation and inﬂammatory molecules at
an early stage facilitates the chemically induced tumour
development in a later stage [3,13]. A time dependent
increase in the [methyl-3H] thymidine incorporation in F1
mouse lung DNA and the overexpression of PCNA suggest
the role of these molecules at an early stage of development
during the lactation period. This observation is supported
by the earlier studies on the expression of proliferation
marker PCNA [10].
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Fig. 4. Status of miR-155 and PARP. The relative fold change of miR-155 expression in F1 lung tissue is shown in (I). The result was  normalized against
the  expression level of U6. Western blot and quantitative analysis of cleaved-PARP are shown in (IIa) and (IIb). Bars represent mean ± SE of triplicate.
*,†P < 0.05; **,††P < 0.01; *,**compared with control; †,††compared with ENU. Evaluation of apoptosis by TUNEL assay in F1 lung tissue sections from ENU
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External stimuli are shown to enhance IL-6 and COX-
 via NF-B (p50) activation [13,38]. Similarly, we  have
lso shown that the ENU exposed mothers can also trigger
he inﬂammatory regulators and create microenvironment
ausing the lymphocytic inﬁltration and hyperplasia in
ffsprings. This is well supported by the earlier report
39] showing the accumulation of lymphocytic inﬁltra-
ion precedes the inﬂammation that could be inhibited
y the chemopreventive agents [12,38]. Prevention of the
NU caused alterations by IP6 show the sensitivity of the
olecules towards the antitumour agents. Beside this, the
revention of inﬂammation and hyperplasia in terms of
L-6, COX-2 and NF-B (p50) in F1 mouse from the ENU
xposed mothers drinking IP6 suggests its chemopreven-
ive effects as early as the time of lactation. Activation of
F-B (p50) and STAT3 is well known to contribute in the
egulation of inﬂammation and cell proliferation [13]. Our
nalysis showed that the activated NF-B (p50) and STAT3
ould regulate many of the genes involved in the regula-
ion of inﬂammation, proliferation and the inhibition of
he apoptotic machinery and their sensitivity towards the
hemopreventive agent, IP6.
Akt pathway is an important target for the anticancer
rug development as it plays an important role in the reg-
lation of cell proliferation and inﬂammation, by regulating
yclin D1 and NF-B [20] and also in regulating the apopto-
is. Our results showing the activation of the Akt pathway cells is stained brown with DAB and is shown by arrows at magniﬁcation
PND24.
by rapidly inducing the phosphorylation of Akt in the early
stages of development of F1 mice from the predisposed
mothers are in accordance with the previous reports [19].
Increasing interest in the strategies for cancer preven-
tion, chemopreventive approaches have been used either
to suppress or prevent the initial phases of tumourigenesis
like cell proliferation, inﬂammation and induce apopto-
sis. Chemopreventive agents such as indole-3-carbinol and
epigallocatechin gallate are known to suppress Akt activa-
tion and promote apoptosis [37]. IP6 supplementation to
predisposed mothers prevented the Akt activation in the
offsprings possibly by reducing the Akt phosphorylation
suggesting that the related molecules could also be con-
trolled by the IP6. As most of the chemopreventive agents
inhibit the carcinogenesis by inducing the apoptosis [37],
the induction of apoptosis is among the important strate-
gies for the development of anticancer drugs [9,8,14]. In
the same line of studies, we  showed the downregulation of
the expression of caspase-9 and caspase-3 in F1 mice from
the ENU exposed mothers and its prevention by the IP6.
Functional activity of the overexpressed genes supported
the prevention and the onset of the apoptosis in the early
stages after the exposure.Activation of PARP, a result of an activated caspase-3,
causes DNA fragmentation [15]. Our results on the inhibi-
tion of DNA fragmentation suggest the reduced apoptosis
in F1 mice from the ENU exposed mothers which appeared
ogy Repo
[
[
[
[
[
[
[
[
[
[
[
[598 S. Sahay et al. / Toxicol
to be reversed in the presence of IP6 possibly due to the
increased DNA fragmentation as a result of PARP cleav-
age. We  infer that the inhibition of lymphocytic inﬁltration
and hyperplasia by IP6 could be due to the induction of
apoptotic events as reported by others [32].
MicroRNAs, the short non-coding RNAs, inﬂuence
a variety of cellular functions, including proliferation,
inﬂammation and apoptosis [27]. MiR-155 has been shown
to predominantly conﬁne to endothelial and immune cells
and gets upregulated to promote the cell proliferation
[24–26]. We  have shown that ENU promoted the lym-
phocytic inﬁltration, during the lactation and we  also
showed the relationship between the lymphocytic inﬁl-
tration and the status of nir155. The downregulation of
miR-155 expression is also associated with induction of
apoptosis through the activation of caspase-3 which has
been identiﬁed as a novel target of miR-155 [27]. In accor-
dance with the earlier reports, our results show that the
upregulation of miR-155 in F1 mice from the ENU exposed
mother could be the cause of the downregulation of apop-
totic events. This is supported by the inhibitory effects of
IP6 on the expression of miR-155 and causing apoptosis
possibly through a caspase-3 mediated mechanism in F1
mice from predisposed mothers.
5. Conclusion
Our results clearly showed that proliferation, inﬂamma-
tion, apoptotic molecules as well as miR-155 are affected
in F1 mice from the mothers predisposed to carcinogen
and could be the cause of the lymphocytic inﬁltrations
and development of hyperplasia as early as at the PND12
and 24. However, predisposed mothers taking antitumour
agents during this (lactation) period could prevent the
lymphocytic inﬁltration and hyperplasia in F1 mice and
effectively modulate the critical events involved in prolif-
eration, inﬂammation and apoptosis.
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